Charles River Labs Intl buy JPMorgan Chase & Co.
Start price
15.02.24
/
50%
€227.80
Target price
15.02.25
€259.70
Performance (%)
-36.02%
End price
16.02.25
€145.75
Summary
This prediction ended on 16.02.25 with a price of €145.75. The BUY prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl performed very badly with a performance of -36.02%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | 5.406% | 5.406% | -6.772% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $270.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€211.90
20.12.23
20.12.23
€246.65
20.12.24
20.12.24
-15.24%
21.12.24
21.12.24
Charles River Labs Intl
Start price
Target price
Perf. (%)
€198.20
10.08.23
10.08.23
€227.00
10.08.24
10.08.24
-7.39%
11.08.24
11.08.24